CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered Sprays, Wellness BioSciences Rx
Wellness BioSciences
Class I - Dangerous
Marketed Without an Approved NDA/ANDA
💊
Prescription Drugs
💊 Drugs • 12,141 recalls
Class I - Dangerous
Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.
Tadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-487-52
Northwind Pharmaceuticals
Class I - Dangerous
CGMP Deviations
Glimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDC 51655-120-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Northwind Pharmaceuticals
Class I - Dangerous
CGMP Deviations
Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44
SCA Pharmaceuticals
Class I - Dangerous
Subpotent Drug: Out of specification results for low potency was obtained.
C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402
Pharmacy Plus, Inc.
Class I - Dangerous
Lack of assurance of sterility.
Class I - Dangerous
Failed Dissolution Specifications: Out of specification dissolution results above specified values.
Class I - Dangerous
Out of specification (OOS) for Spectroscopic Identification test by IR.
Class I - Dangerous
Labeling; Incorrect NDC number on outer carton of product.
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Class I - Dangerous
CGMP Deviations: Discoloration
Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.
Class I - Dangerous
Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring.
Class I - Dangerous
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1
Preferred Pharmaceuticals
Class I - Dangerous
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Carton NDC 0093-7487-56, Packet NDC 0093-7487-19
Teva Pharmaceuticals USA
Class I - Dangerous
Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.
Class I - Dangerous
cGMP Deviations
Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9
Preferred Pharmaceuticals
Class I - Dangerous
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9
Preferred Pharmaceuticals
Class I - Dangerous
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9
Preferred Pharmaceuticals
Class I - Dangerous
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.